Stock valuation scanner
Prioritize stocks to research, not magic buy signals.
The scanner combines valuation, financial quality, growth, risk and technical context to build a research shortlist.
Server-side cached data connected. 2026-07-11T19:25:00+00:00
How to read this scanner
This scanner ranks companies for further research. It does not produce automatic buy or sell signals.
Read the methodology| Ticker | Company | Sector | Price | Market cap | P/E | Forward P/E | Intrinsic value | Base upside | ROE | EPS growth | Beta | Score | Confidence | Maximum risk | Analysis |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABUS Nasdaq Alpha Vantage Stale |
Arbutus Biopharma Corporation - Common Stock | HEALTHCARE | Quote missing | $962M | 5.87 | 10.25 |
USD 12.21 - USD 18.31 Base USD 15.26 |
N/A | 94.7% | 0.0% | 0.62 | 69 | 72/100 | Low Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| AAPL Nasdaq Alpha Vantage Stale |
Apple Inc. - Common Stock | TECHNOLOGY | Quote missing | $4.25T | 35.07 | 30.40 |
USD 216.93 - USD 325.39 Base USD 271.16 |
N/A | 141.5% | 21.8% | 1.09 | 65 | 72/100 | Low Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| AAON Nasdaq Alpha Vantage Stale |
AAON, Inc. - Common Stock | INDUSTRIALS | Quote missing | $10.4B | 89.28 | 60.98 |
USD 53.47 - USD 80.21 Base USD 66.84 |
N/A | 13.5% | 37.1% | 1.40 | 63 | 72/100 | Medium Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| ABNB Nasdaq Alpha Vantage Stale |
Airbnb, Inc. - Class A Common Stock | CONSUMER CYCLICAL | Quote missing | $88.4B | 36.77 | 28.33 |
USD 90.22 - USD 135.33 Base USD 112.77 |
N/A | 32.3% | 6.0% | 1.16 | 62 | 72/100 | Medium Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| ACAD Nasdaq Alpha Vantage Stale |
ACADIA Pharmaceuticals Inc. - Common Stock | HEALTHCARE | Quote missing | $4.5B | 11.64 | 77.52 |
USD 38.39 - USD 57.59 Base USD 47.99 |
N/A | 37.3% | -81.8% | 0.80 | 54 | 72/100 | Low Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| ACFN Nasdaq Alpha Vantage Fresh |
Acorn Energy, Inc. - Common Stock | TECHNOLOGY | Quote missing | $42M | 21.96 | 98.04 |
USD 12.05 - USD 18.08 Base USD 15.06 |
N/A | 27.4% | -79.9% | 0.24 | 54 | 72/100 | Low Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| ABEO Nasdaq SEC Alpha Vantage Partial |
Abeona Therapeutics Inc. - Common Stock | HEALTHCARE | Quote missing | $345M | 6.37 | 526.32 |
USD 15.77 - USD 23.65 Base USD 19.71 |
N/A | -11.8% | -129.7% | 1.35 | 52 | 64/100 | Medium Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| AACB Nasdaq SEC Alpha Vantage Derived Stale |
Artius II Acquisition Inc. - Class A Ordinary Shares | FINANCIAL SERVICES | USD 10.49 | $233M | 31.82 | N/A |
N/A Quote missing |
N/A | 0.0% | 0.0% | N/A | 46 | 60/100 | Low Fundamentals pending |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| ABVC Nasdaq Alpha Vantage Partial |
ABVC BioPharma, Inc. - Common Stock | HEALTHCARE | Quote missing | $52M | N/A | N/A |
USD 1.62 - USD 2.42 Base USD 2.02 |
N/A | -87.8% | 0.0% | 0.54 | 44 | 59/100 | Low Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| ABCL Nasdaq Alpha Vantage Stale |
AbCellera Biologics Inc. - Common Shares | HEALTHCARE | Quote missing | $2.3B | N/A | 27.55 |
USD 8.34 - USD 12.52 Base USD 10.43 |
N/A | -14.7% | 45.9% | 1.20 | 43 | 59/100 | Medium Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| ABTC Nasdaq Alpha Vantage Stale |
American Bitcoin Corp. - Class A Common Stock | FINANCIAL SERVICES | Quote missing | $835M | N/A | 71.43 |
USD 3.20 - USD 4.80 Base USD 4.00 |
N/A | -33.2% | 0.0% | N/A | 43 | 59/100 | Low Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| AAME Nasdaq Alpha Vantage Stale |
Atlantic American Corporation - Common Stock | FINANCIAL SERVICES | Quote missing | $35M | 7.48 | 7.39 |
USD 2.39 - USD 3.59 Base USD 2.99 |
N/A | 4.8% | -78.4% | 0.74 | 43 | 62/100 | Low Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| ABAT Nasdaq SEC Alpha Vantage Partial |
American Battery Technology Company - Common Stock | INDUSTRIALS | Quote missing | $386M | N/A | 37.74 |
USD 5.20 - USD 7.80 Base USD 6.50 |
N/A | -30.0% | 39.5% | 1.13 | 40 | 59/100 | Low Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| AAL Nasdaq Alpha Vantage Stale |
American Airlines Group, Inc. - Common Stock | INDUSTRIALS | Quote missing | $11.8B | 57.65 | 55.87 |
USD 7.18 - USD 10.77 Base USD 8.98 |
N/A | 0.0% | -83.1% | 1.37 | 39 | 72/100 | Medium Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| AAPG Nasdaq SEC Alpha Vantage Stale |
Ascentage Pharma Group International - American Depository Shares | HEALTHCARE | Quote missing | $1.7B | N/A | N/A |
USD 38.05 - USD 57.07 Base USD 47.56 |
N/A | -154.6% | 0.0% | 0.65 | 35 | 59/100 | Low Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| AARD Nasdaq Alpha Vantage Stale |
Aardvark Therapeutics, Inc. - Common Stock | HEALTHCARE | Quote missing | $113M | N/A | N/A |
USD 12.35 - USD 18.53 Base USD 15.44 |
N/A | -58.8% | 0.0% | N/A | 35 | 59/100 | Low Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| AAOI Nasdaq Alpha Vantage Stale |
Applied Optoelectronics, Inc. - Common Stock | TECHNOLOGY | Quote missing | $10.9B | N/A | 84.03 |
USD 121.04 - USD 181.56 Base USD 151.30 |
N/A | -6.1% | 0.0% | 3.67 | 34 | 51/100 | High Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| ACB Nasdaq SEC Alpha Vantage Partial |
Aurora Cannabis Inc. - Common Shares | HEALTHCARE | Quote missing | $165M | N/A | 19.16 |
USD 4.98 - USD 7.48 Base USD 6.23 |
N/A | -10.5% | 0.0% | 1.35 | 34 | 59/100 | Medium Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| ACDC Nasdaq Alpha Vantage Stale |
ProFrac Holding Corp. - Class A Common Stock | ENERGY | Quote missing | $919M | N/A | 16.16 |
USD 4.07 - USD 6.11 Base USD 5.09 |
N/A | -44.1% | -99.1% | 1.42 | 27 | 59/100 | Medium Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
| ACET Nasdaq Alpha Vantage Fresh |
Adicet Bio, Inc. - Common Stock | HEALTHCARE | Quote missing | $84M | N/A | N/A |
USD 27.86 - USD 41.80 Base USD 34.83 |
N/A | -72.2% | 0.0% | 1.59 | 26 | 51/100 | High Quote missing |
|
Short thesisFundamentals available; quote data is missing, so valuation gap is not computed yet. Current model: SEC/Nasdaq data first, then optional quote-provider enrichment. Without a price, the scanner shows a missing quote state instead of inventing valuation. |
|||||||||||||||
No stock matches the current filters.
Scoring methodology
Global score = 40% valuation, 25% quality, 15% growth, 15% risk, 5% technical. It prioritizes research, it does not produce automatic buy instructions.
News and sentiment widgets stay hidden until a news provider is connected. Macro assumptions use configurable defaults when FRED/BEA are not configured.
For educational and informational purposes only. Data may be delayed, incomplete or inaccurate. Always verify with official filings and your own analysis.
How is the score built? Read the full Bullish Stock Alerts methodology before using scanner outputs.
